Acta Neuropathologica

, Volume 84, Issue 6, pp 606–612 | Cite as

Expression of leukocyte antigen CD34 by brain capillaries in Alzheimer's disease and neurologically normal subjects

  • Rajesh N. Kalaria
  • Stephanie N. Kroon
Regular Papers


We studied the expression of a hemopoietic progenitor cell antigen, designated CD34, in brains from subjects with Alzheimer's disease (AD) and nonneurological controls. Immunoblots of brain microvessel proteins probed with monoclonal antibody QBEND/10 to the leukocyte antigen CD34 recognized a protein band with an apparent molecular mass of 90–100 kDa. Immunocytochemical staining of brain tissue sections showed CD34 to be expressed by all microvasculature including those of the circumventricular organs. In normal control brains such specific staining exhibited by QBEND/10 was indistinguishable from that obtained with collagen IV antibodies. In AD, however, increased vascular tendrils in form of endothelial abluminal processes and intraparenchymal abnormalities were evident in cortical and hippocampal regions, predominant in cases with severe pathology. Our results demonstrate that the leukocyte antigen CD34 is localized with the vascular endothelium throughout the human brain. These results also suggest that CD34 detects endothelial abnormalities in brains of AD subjects and support previous observations on the usefulness of CD34 to label abluminal microprocesses.

Key words

Alzheimer's disease Brain endothelium Blood-brain barrier Hemopoietic progenitor cells Leukocyte antigen CD34 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Bell MA, Ball MJ (1990) Neuritic plaques and vessels of visual cortex in aging and Alzheimer's dementia. Neurobiol Aging 11:359–370Google Scholar
  2. 2.
    Beschorner WE, Civin CI, Strauss LC (1985) Localization of hematopoietic progenitor cells in tissue with the anti-My-10 monoclonal antibody. Am J Pathol 119:1–4Google Scholar
  3. 3.
    Boyd AW (1987) Human leukocyte antigens: an update on structure, function and nomenclature. Pathology 19:329–337Google Scholar
  4. 4.
    Delacourte A (1990) General and dramatic glial reaction in Alzheimer brains. Neurology 40:33–37Google Scholar
  5. 5.
    Duffy PE, Rapport M, Graf L (1980) Glial fibrillary acidic protein and Alzheimer-type senile dementia. Neurology 30:778–780Google Scholar
  6. 6.
    Fischer VW, Siddiqi A, Yusufaly Y (1990) Altered angioarchitecture in selected areas of brains with Alzheimer's disease. Acta Neuropathol 79:672–679Google Scholar
  7. 7.
    Geddes JW, Monaghan DT, Cotman CW, Lott IT, Kim RC, Chui HC (1985) Plasticity of hippocampal circuitry in Alzheimer's disease. Science 230:1179–1181Google Scholar
  8. 8.
    Geddes JW, Anderson KJ, Cotman CW (1986) Senile plaques as aberrant sprout-stimulating structures. Exp Neurol 94:767–776Google Scholar
  9. 9.
    Hsu SM, Raine L, Fanger H (1981) Use of avidin-biotinperoxidase complex (ABC) in immunoperoxidase techniques. A comparison between ABC and unlabeled antibody (PAP) procedures. J Histochem Cytochem 59:777–783Google Scholar
  10. 10.
    Kalaria RN, Grahovac I (1990) Serum amyloid P immunoreactivity in hippocampal tangles, plaques and vessels: implications for leakage across the blood-brain barrier in Alzheimer's disease. Brain Res 516:349–353Google Scholar
  11. 11.
    Kalaria RN, Gravina SA, Schmidley JW, Perry G, Harik SI (1988) The glucose transporter of the human brain and blood-brain barrier. Ann Neurol 24:757–764Google Scholar
  12. 12.
    Kalaria RN, Mitchell MJ, Grahovac I, Harik SI (1989) Chemical pathology of cerebral microvessels in Alzheimer's disease (AD). J Neurochem 52 [Suppl]:S44Google Scholar
  13. 13.
    Kalaria RN, Galloway PG, Perry G (1991) Widespread amyloid P component immunoreactivity in cortical amyloid deposits of Alzheimer's disease and other degenerative disorders. Neuropathol Appl Neurobiol 17:189–201Google Scholar
  14. 14.
    Kalaria RN, Sromek SM, Grahovac I, Harik SI (1992) Transferrin receptors of human and rat cerebral microvessels and brain: assessment in Alzheimer's Disease. Brain Res 585:87–93Google Scholar
  15. 15.
    Kawai M, Kalaria RN, Harik SI, Perry G (1990) The relationship of amyloid plaques to cerebral capillaries in Alzheimer's disease. Am J Pathol 137:1435–1446Google Scholar
  16. 16.
    McGeer PL, Zhu SG, Dedhar S (1990) Immunostaining of human brain capillaries by antibodies to very late antigens. J Neuroimmunol 26:213–218Google Scholar
  17. 17.
    Perlmutter LS, Chui HC (1990) Microangiopathy, the vascular basement membrane and Alzheimer's disease: a review. Brain Res Bull 24:677–686Google Scholar
  18. 18.
    Schlingemann RO, Rietveld FJR, de Waal RMW, Bradley NJ, Skene AI, Davies AJS, Greaves MF, Denekamp GJ, Ruiter DJ (1990) Leukocyte antigen CD34 is expressed by a subset of cultured endothelial cells and on endothelial abluminal microprocesses in the tumor stroma. Lab Invest 62:690–696Google Scholar
  19. 19.
    Watt SM, Karhi K, Gatter K, Furley AJW, Katz FE, Healy LE, Altass LJ, Bradley NJ, Sutherland DR, Levinsky R, Greaves MF (1987) Distribution and epitope analysis of the cell membrane glycoprotein (HPCA-1) associated with human hemopoietic progenitor cells. Leukemia 1:417–426Google Scholar
  20. 20.
    Williams SK, Gillis JF, Matthews MA, Wagner RC, Bitensky MW (1980) Isolation and characterization of brain endothelial cells: morphology and enzyme activity. J Neurochem 35:374–381Google Scholar

Copyright information

© Springer-Verlag 1992

Authors and Affiliations

  • Rajesh N. Kalaria
    • 1
    • 2
  • Stephanie N. Kroon
    • 1
    • 2
  1. 1.Department of NeurologyCase Western Reserve University School of MedicineClevelandUSA
  2. 2.Department of NeurosciencesCase Western Reserve University School of MedicineClevelandUSA

Personalised recommendations